ArticleFrontiers in oncology2022

Development and Validation of Prognostic Model for Lung Adenocarcinoma Patients Based on m6A Methylation Related Transcriptomics.

Huijun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.